Neuman Linda L 4
4 · Aeglea BioTherapeutics, Inc. · Filed Jan 27, 2023
Insider Transaction Report
Form 4
Neuman Linda L
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-11-14+25,000→ 25,000 totalExercise: $1.36Exp: 2032-11-13→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock options will vest as to 1/4th of the total shares on November 14, 2023, and then 1/48th of the shares will vest monthly thereafter, such that the option will become fully vested on November 14, 2026, subject to the Reporting Person's provision of service to the issuer on each vesting date.